{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T07:40:01Z","timestamp":1752133201680,"version":"3.41.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,10]]},"DOI":"10.7759\/cureus.87643","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T07:04:22Z","timestamp":1752131062000},"source":"Crossref","is-referenced-by-count":0,"title":["A Study of Transplacental Transfer of SARS-CoV-2 Antibodies in COVID-19 Vaccinated Women in Mumbai, India"],"prefix":"10.7759","author":[{"given":"Disha","family":"Bhanushali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreyans","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shashikala","family":"Shivaprakash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipti","family":"Dhanwate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maninder S","family":"Setia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. Listings of WHO\u2019s response to COVID-19. (2021). Accessed: April 14, 2025: https:\/\/www.who.int\/news\/item\/29-06-2020-covidtimeline."},{"key":"ref2","unstructured":"World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. (2020). Accessed: April 14, 2025: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance\/naming-the-coronavirus-disease-(co...."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00480","article-title":"Treatment options for COVID-19: a review","volume":"7","author":"Ali MJ","year":"2020","unstructured":"Ali MJ, Hanif M, Haider MA, et al.. Treatment options for COVID-19: a review. Front Med (Lausanne). 2020, 7:480. 10.3389\/fmed.2020.00480","journal-title":"Front Med (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1713004","article-title":"Interim management of COVID-19 by repurposed homeopathic medicines","volume":"109","author":"Basu N","year":"2020","unstructured":"Basu N, Das BC, Tandon S. Interim management of COVID-19 by repurposed homeopathic medicines. Homeopathy. 2020, 109:182-3. 10.1055\/s-0040-1713004","journal-title":"Homeopathy"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4806.20.06664-1","article-title":"Lessons from the Italian COVID-19 frontline","volume":"111","author":"Bellan M","year":"2020","unstructured":"Bellan M, Sainaghi PP, Gavelli F, et al.. Lessons from the Italian COVID-19 frontline. Minerva Med. 2020, 111:303-5. 10.23736\/S0026-4806.20.06664-1","journal-title":"Minerva Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.21315\/mjms2020.27.4.15","article-title":"Ivermectin: potential role as repurposed drug for COVID-19","volume":"27","author":"Dixit A","year":"2020","unstructured":"Dixit A, Yadav R, Singh AV. Ivermectin: potential role as repurposed drug for COVID-19. Malays J Med Sci. 2020, 27:154-8. 10.21315\/mjms2020.27.4.15","journal-title":"Malays J Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2020.07.006","article-title":"Antivirals for COVID-19: a critical review","volume":"9","author":"Frediansyah A","year":"2021","unstructured":"Frediansyah A, Tiwari R, Sharun K, et al.. Antivirals for COVID-19: a critical review. Clin Epidemiol Glob Health. 2021, 9:90-8. 10.1016\/j.cegh.2020.07.006","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8835627","article-title":"The role of therapeutic anticoagulation in COVID-19","volume":"2020","author":"McGovern R","year":"2020","unstructured":"McGovern R, Conway P, Pekrul I, Tujjar O. The role of therapeutic anticoagulation in COVID-19. Case Rep Crit Care. 2020, 2020:8835627. 10.1155\/2020\/8835627","journal-title":"Case Rep Crit Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.04.035","article-title":"Pharmacotherapy in COVID-19; A narrative review for emergency providers","volume":"38","author":"Mehta N","year":"2020","unstructured":"Mehta N, Mazer-Amirshahi M, Alkindi N, Pourmand A. Pharmacotherapy in COVID-19; A narrative review for emergency providers. Am J Emerg Med. 2020, 38:1488-93. 10.1016\/j.ajem.2020.04.035","journal-title":"Am J Emerg Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.infpip.2020.100061","article-title":"Therapeutic management of patients with COVID-19: a systematic review","volume":"2","author":"Tobaiqy M","year":"2020","unstructured":"Tobaiqy M, Qashqary M, Al-Dahery S, et al.. Therapeutic management of patients with COVID-19: a systematic review. Infect Prev Pract. 2020, 2:100061. 10.1016\/j.infpip.2020.100061","journal-title":"Infect Prev Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/abt\/tbaa010","article-title":"Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates","volume":"3","author":"Verma HK","year":"2020","unstructured":"Verma HK, Farran B, Bhaskar LV. Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates. Antib Ther. 2020, 3:115-25. 10.1093\/abt\/tbaa010","journal-title":"Antib Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101086","article-title":"A review on current COVID-19 vaccines and evaluation of particulate vaccine delivery systems","volume":"9","author":"Shah SM","year":"2021","unstructured":"Shah SM, Alsaab HO, Rawas-Qalaji MM, Uddin MN. A review on current COVID-19 vaccines and evaluation of particulate vaccine delivery systems. Vaccines (Basel). 2021, 9:10.3390\/vaccines9101086","journal-title":"Vaccines (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2066425","article-title":"COVID-19 vaccination challenges: a mini-review","volume":"18","author":"Mohseni Afshar Z","year":"2022","unstructured":"Mohseni Afshar Z, Barary M, Hosseinzadeh R, et al.. COVID-19 vaccination challenges: a mini-review. Hum Vaccin Immunother. 2022, 18:2066425. 10.1080\/21645515.2022.2066425","journal-title":"Hum Vaccin Immunother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5334\/aogh.4484","article-title":"Assessing the impact of COVID-19 vaccination programs on the reduction of COVID-19 cases: a systematic literature review","volume":"90","author":"Sibanda B","year":"2024","unstructured":"Sibanda B, Haryanto B. Assessing the impact of COVID-19 vaccination programs on the reduction of COVID-19 cases: a systematic literature review. Ann Glob Health. 2024, 90:45. 10.5334\/aogh.4484","journal-title":"Ann Glob Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0276759","article-title":"Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin (R)) in healthcare workers in Mumbai, India: a retrospective cohort analysis","volume":"17","author":"Contractor A","year":"2022","unstructured":"Contractor A, Shivaprakash S, Tiwari A, et al.. Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin (R)) in healthcare workers in Mumbai, India: a retrospective cohort analysis. PLoS One. 2022, 17:e0276759. 10.1371\/journal.pone.0276759","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101097","article-title":"COVID-19 vaccinations: a comprehensive review of their safety and efficacy in special populations","volume":"9","author":"Yan Z","year":"2021","unstructured":"Yan Z, Yang M, Lai CL. COVID-19 vaccinations: a comprehensive review of their safety and efficacy in special populations. Vaccines (Basel). 2021, 9:10.3390\/vaccines9101097","journal-title":"Vaccines (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.18213","article-title":"Acceptance and hesitancy towards COVID-19 vaccines in rural and tribal areas of Maharashtra (India)","volume":"18","author":"Setia MS","year":"2024","unstructured":"Setia MS, Tawde A, Relwani N, et al.. Acceptance and hesitancy towards COVID-19 vaccines in rural and tribal areas of Maharashtra (India). J Infect Dev Ctries. 2024, 18:719-25. 10.3855\/jidc.18213","journal-title":"J Infect Dev Ctries"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07856-8","article-title":"COVID-19 vaccination in pregnancy: views and vaccination uptake rates in pregnancy, a mixed methods analysis from SAIL and the born-in-Wales birth cohort","volume":"22","author":"Mhereeg M","year":"2022","unstructured":"Mhereeg M, Jones H, Kennedy J, et al.. COVID-19 vaccination in pregnancy: views and vaccination uptake rates in pregnancy, a mixed methods analysis from SAIL and the born-in-Wales birth cohort. BMC Infect Dis. 2022, 22:932. 10.1186\/s12879-022-07856-8","journal-title":"BMC Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20210458","article-title":"The prevalence of COVID-19 vaccination and vaccine hesitancy in pregnant women: an internet-based cross-sectional study in Japan","volume":"32","author":"Hosokawa Y","year":"2022","unstructured":"Hosokawa Y, Okawa S, Hori A, et al.. The prevalence of COVID-19 vaccination and vaccine hesitancy in pregnant women: an internet-based cross-sectional study in Japan. J Epidemiol. 2022, 32:188-94. 10.2188\/jea.JE20210458","journal-title":"J Epidemiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2021.1949293","article-title":"COVID-19 vaccines: concerns beyond protective efficacy and safety","volume":"20","author":"Lai CC","year":"2021","unstructured":"Lai CC, Chen IT, Chao CM, et al.. COVID-19 vaccines: concerns beyond protective efficacy and safety. Expert Rev Vaccines. 2021, 20:1013-25. 10.1080\/14760584.2021.1949293","journal-title":"Expert Rev Vaccines"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2309","article-title":"Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities","volume":"32","author":"Mohseni Afshar Z","year":"2022","unstructured":"Mohseni Afshar Z, Babazadeh A, Janbakhsh A, et al.. Coronavirus disease 2019 (Covid-19) vaccination recommendations in special populations and patients with existing comorbidities. Rev Med Virol. 2022, 32:e2309. 10.1002\/rmv.2309","journal-title":"Rev Med Virol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10050766","article-title":"Uptake of COVID-19 vaccines among pregnant women: a systematic review and meta-analysis","volume":"10","author":"Galanis P","year":"2022","unstructured":"Galanis P, Vraka I, Siskou O, et al.. Uptake of COVID-19 vaccines among pregnant women: a systematic review and meta-analysis. Vaccines (Basel). 2022, 10:10.3390\/vaccines10050766","journal-title":"Vaccines (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2022.101144","article-title":"The prevalence of COVID vaccine acceptance among pregnant women: a systematic review and meta-analysis","volume":"17","author":"Halemani K","year":"2022","unstructured":"Halemani K, Dhiraaj S, Latha T, et al.. The prevalence of COVID vaccine acceptance among pregnant women: a systematic review and meta-analysis. Clin Epidemiol Glob Health. 2022, 17:None. 10.1016\/j.cegh.2022.101144","journal-title":"Clin Epidemiol Glob Health"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2022.100616","article-title":"COVID-19 vaccination among pregnant people in the United States: a systematic review","volume":"4","author":"Rawal S","year":"2022","unstructured":"Rawal S, Tackett RL, Stone RH, Young HN. COVID-19 vaccination among pregnant people in the United States: a systematic review. Am J Obstet Gynecol MFM. 2022, 4:100616. 10.1016\/j.ajogmf.2022.100616","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1101\/2021.12.09.21267423","article-title":"Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and early infancy","author":"Prahl M","year":"2021","unstructured":"Prahl M, Golan Y, Cassidy AG, et al.. Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and early infancy. medRxiv. 2021, 10.1101\/2021.12.09.21267423","journal-title":"medRxiv"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-61496-3","article-title":"Efficient transplacental transfer of SARS-CoV-2 antibodies between naturally exposed mothers and infants in Accra, Ghana","volume":"14","author":"Partey FD","year":"2024","unstructured":"Partey FD, Obiri D, Bonney EY, et al.. Efficient transplacental transfer of SARS-CoV-2 antibodies between naturally exposed mothers and infants in Accra, Ghana. Sci Rep. 2024, 14:10772. 10.1038\/s41598-024-61496-3","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031516","article-title":"Placental transfer efficiency of neutralizing antibodies on SARS-CoV-2 vaccination before and after pregnancy in Mexican women","volume":"25","author":"Mart\u00ednez-Quezada R","year":"2024","unstructured":"Mart\u00ednez-Quezada R, Miguel-Rodr\u00edguez CE, Ram\u00edrez-Lozada T, et al.. Placental transfer efficiency of neutralizing antibodies on SARS-CoV-2 vaccination before and after pregnancy in Mexican women. Int J Mol Sci. 2024, 25:10.3390\/ijms25031516","journal-title":"Int J Mol Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109273","article-title":"Placental transfer dynamics and durability of maternal COVID-19 vaccine-induced antibodies in infants","volume":"27","author":"Lopez PA","year":"2024","unstructured":"Lopez PA, Nziza N, Chen T, et al.. Placental transfer dynamics and durability of maternal COVID-19 vaccine-induced antibodies in infants. iScience. 2024, 27:109273. 10.1016\/j.isci.2024.109273","journal-title":"iScience"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31169-8","article-title":"Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms","volume":"13","author":"Atyeo CG","year":"2022","unstructured":"Atyeo CG, Shook LL, Brigida S, et al.. Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms. Nat Commun. 2022, 13:3571. 10.1038\/s41467-022-31169-8","journal-title":"Nat Commun"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.06.032","article-title":"COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn","volume":"41","author":"Munoz FM","year":"2023","unstructured":"Munoz FM, Posavad CM, Richardson BA, et al.. COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn. Vaccine. 2023, 41:5296-303. 10.1016\/j.vaccine.2023.06.032","journal-title":"Vaccine"},{"key":"ref31","unstructured":"Serum Institute of India. Coronavirus disease (COVID-19): vaccines. (2025). Accessed: April 14, 2025: https:\/\/www.seruminstitute.com\/product_covishield.php#:~:text=Both%20COVISHIELD%E2%84%A2%20(manufactured%20by,Corona%...."},{"key":"ref32","unstructured":"Bharat Biotech. COVAXIN\u00ae: India's first indigenous COVID-19 vaccine. (2025). Accessed: April 14, 2025: https:\/\/www.bharatbiotech.com\/covaxin.html#:~:text=COVAXIN%C2%AE%20%2D%20India's%20First,Institute%20of%20Virology%20...."},{"key":"ref33","unstructured":"Roche. Elecsys\u00ae anti-SARS-CoV-2 S. (2020). Accessed: April 14, 2025: https:\/\/diagnostics.roche.com\/global\/en\/products\/lab\/elecsys-anti-sars-cov-2-s-cps-000616.html."},{"key":"ref34","unstructured":"Roche. Elecsys \u00ae anti-SARS-CoV-2 immunoassay for the qualitative detection of antibodies against SARS-CoV-2. (2020). Accessed: April 14, 2025: https:\/\/diagnostics.roche.com\/content\/dam\/diagnostics\/Blueprint\/en\/pdf\/cps\/Elecsys-Anti-SARS-CoV-2-factsheet.pdf."},{"key":"ref35","unstructured":"BioSystems. GENLISA\u2122 SARS-CoV-2 (Covid-19) surrogate virus neutralization test (sVNT) ELISA. (2023). Accessed: April 14, 2025: https:\/\/www.krishgen.com\/upload\/datasheets\/KBVH400_GENLISAT-SARS-CoV-2-(Covid-19)-Surrogate-Virus-Neutralization-Test...."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154834","article-title":"Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine","volume":"131","author":"Beharier O","year":"2021","unstructured":"Beharier O, Plitman Mayo R, Raz T, et al.. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. J Clin Invest. 2021, 131:10.1172\/JCI154834","journal-title":"J Clin Invest"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/biom14040435","article-title":"COVID-vaccines in pregnancy: maternal and neonatal response over the first 9 months after delivery","volume":"14","author":"Proto A","year":"2024","unstructured":"Proto A, Agliardi S, Pani A, et al.. COVID-vaccines in pregnancy: maternal and neonatal response over the first 9 months after delivery. Biomolecules. 2024, 14:10.3390\/biom14040435","journal-title":"Biomolecules"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.5812\/archcid-139871","article-title":"Transplacental transfer efficiency of SARS-CoV-2-specific IgG antibodies in Iranian seropositive mothers: a monocentric study in Karaj, Iran","volume":"18","author":"Farahani M","year":"2023","unstructured":"Farahani M, Alirezaie B, Padyab M, et al.. Transplacental transfer efficiency of SARS-CoV-2-specific IgG antibodies in Iranian seropositive mothers: a monocentric study in Karaj, Iran. Arch Clin Infect Dis. 2023, 18:139871.","journal-title":"Arch Clin Infect Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piae085","article-title":"Evaluation of transplacental maternal SARS-CoV-2 antibody transfer in small for gestational age infants","volume":"13","author":"Kachikis A","year":"2024","unstructured":"Kachikis A, Pike M, Eckert LO, et al.. Evaluation of transplacental maternal SARS-CoV-2 antibody transfer in small for gestational age infants. J Pediatric Infect Dis Soc. 2024, 13:585-8. 10.1093\/jpids\/piae085","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.1206","article-title":"Durability of anti-spike antibodies in infants after maternal COVID-19 vaccination or natural infection","volume":"327","author":"Shook LL","year":"2022","unstructured":"Shook LL, Atyeo CG, Yonker LM, et al.. Durability of anti-spike antibodies in infants after maternal COVID-19 vaccination or natural infection. JAMA. 2022, 327:1087-9. 10.1001\/jama.2022.1206","journal-title":"JAMA"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-87535-x","article-title":"Dynamic changes of acquired maternal SARS-CoV-2 IgG in infants","volume":"11","author":"Wang X","year":"2021","unstructured":"Wang X, Yang P, Zheng J, et al.. Dynamic changes of acquired maternal SARS-CoV-2 IgG in infants. Sci Rep. 2021, 11:8021. 10.1038\/s41598-021-87535-x","journal-title":"Sci Rep"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10071143","article-title":"Quantitative analysis of anti-N and anti-S antibody titers of SARS-CoV-2 infection after the third dose of COVID-19 vaccination","volume":"10","author":"Lee N","year":"2022","unstructured":"Lee N, Jeong S, Lee SK, et al.. Quantitative analysis of anti-N and anti-S antibody titers of SARS-CoV-2 infection after the third dose of COVID-19 vaccination. Vaccines (Basel). 2022, 10:10.3390\/vaccines10071143","journal-title":"Vaccines (Basel)"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.40993","article-title":"Comparison of maternal and neonatal antibody levels after COVID-19 vaccination vs SARS-CoV-2 infection","volume":"5","author":"Flannery DD","year":"2022","unstructured":"Flannery DD, Gouma S, Dhudasia MB, et al.. Comparison of maternal and neonatal antibody levels after COVID-19 vaccination vs SARS-CoV-2 infection. JAMA Netw Open. 2022, 5:e2240993. 10.1001\/jamanetworkopen.2022.40993","journal-title":"JAMA Netw Open"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.52387","article-title":"Timing of maternal COVID-19 vaccine and antibody concentrations in infants born preterm","volume":"7","author":"Kachikis A","year":"2024","unstructured":"Kachikis A, Pike M, Eckert LO, et al.. Timing of maternal COVID-19 vaccine and antibody concentrations in infants born preterm. JAMA Netw Open. 2024, 7:e2352387. 10.1001\/jamanetworkopen.2023.52387","journal-title":"JAMA Netw Open"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29125","article-title":"Maternal antibody transfer rate of vaccination against SARS-CoV-2 before or during early pregnancy and its protective effectiveness on offspring","volume":"95","author":"Liu S","year":"2023","unstructured":"Liu S, Wang P, Shi X, et al.. Maternal antibody transfer rate of vaccination against SARS-CoV-2 before or during early pregnancy and its protective effectiveness on offspring. J Med Virol. 2023, 95:e29125. 10.1002\/jmv.29125","journal-title":"J Med Virol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/381103-a-study-of-transplacental-transfer-of-sars-cov-2-antibodies-in-covid-19-vaccinated-women-in-mumbai-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T07:04:24Z","timestamp":1752131064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/381103-a-study-of-transplacental-transfer-of-sars-cov-2-antibodies-in-covid-19-vaccinated-women-in-mumbai-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":45,"URL":"https:\/\/doi.org\/10.7759\/cureus.87643","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}